163 related articles for article (PubMed ID: 30305629)
1. Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery.
He R; Yin Y; Yin W; Li Y; Zhao J; Zhang W
Nat Commun; 2018 Oct; 9(1):4183. PubMed ID: 30305629
[TBL] [Abstract][Full Text] [Related]
2. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
Ding L; Han L; Li Y; Zhao J; He P; Zhang W
Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
[TBL] [Abstract][Full Text] [Related]
3. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
[TBL] [Abstract][Full Text] [Related]
4. Gastric Mammalian Target of Rapamycin Signaling Contributes to Inhibition of Ghrelin Expression Induced by Roux-En-Y Gastric Bypass.
Li D; Li S; Pan Q; Zhai H; Peng M; Wang X; Xu G
Cell Physiol Biochem; 2018; 51(2):664-680. PubMed ID: 30463068
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
6. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
[TBL] [Abstract][Full Text] [Related]
7. Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass.
Liang Y; Yu R; He R; Sun L; Luo C; Feng L; Chen H; Yin Y; Zhang W
Front Endocrinol (Lausanne); 2022; 13():891379. PubMed ID: 36082078
[TBL] [Abstract][Full Text] [Related]
8. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice.
Hao Z; Leigh Townsend R; Mumphrey MB; Gettys TW; Yu S; Münzberg H; Morrison CD; Berthoud HR
Obes Surg; 2018 Oct; 28(10):3227-3236. PubMed ID: 29770924
[TBL] [Abstract][Full Text] [Related]
10. Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.
Hao Z; Mumphrey MB; Townsend RL; Morrison CD; Münzberg H; Ye J; Berthoud HR
Obes Surg; 2016 Sep; 26(9):2173-2182. PubMed ID: 26781597
[TBL] [Abstract][Full Text] [Related]
11. Maternal Roux-en-Y gastric bypass impairs insulin action and endocrine pancreatic function in male F1 offspring.
Pietrobon CB; Bertasso IM; Ribeiro RA; Alegre-Maller ACP; Lubaczeuski C; Boschero AC; Araújo ACF; Balbo SL; Bonfleur ML
Eur J Nutr; 2020 Apr; 59(3):1067-1079. PubMed ID: 30982179
[TBL] [Abstract][Full Text] [Related]
12. Activation of mTORC1 signaling in gastric X/A-like cells induces spontaneous pancreatic fibrosis and derangement of glucose metabolism by reducing ghrelin production.
Yu R; Li Z; Liu S; Huwatibieke B; Li Y; Yin Y; Zhang W
EBioMedicine; 2018 Oct; 36():304-315. PubMed ID: 30266297
[TBL] [Abstract][Full Text] [Related]
13. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
[TBL] [Abstract][Full Text] [Related]
15. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
17. Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice.
Tarasco E; Boyle CN; Pellegrini G; Arnold M; Steiner R; Hornemann T; Nasias D; Kardassis D; Whiting L; Lutz TA
Int J Obes (Lond); 2019 Dec; 43(12):2394-2406. PubMed ID: 31270430
[TBL] [Abstract][Full Text] [Related]
18. mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote Kras
Zhao Y; Schoeps B; Yao D; Zhang Z; Schuck K; Tissen V; Jäger C; Schlitter AM; van der Kammen R; Ludwig C; D'Haese JG; Raulefs S; Maeritz N; Shen S; Zou X; Krüger A; Kleeff J; Michalski CW; Friess H; Innocenti M; Kong B
Gastroenterology; 2021 Apr; 160(5):1755-1770.e17. PubMed ID: 33388318
[TBL] [Abstract][Full Text] [Related]
19. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
20. Constitutive Activation of the Nutrient Sensor mTORC1 in Myeloid Cells Induced by Tsc1 Deletion Protects Mice from Diet-Induced Obesity.
Paschoal VA; Belchior T; Amano MT; Burgos-Silva M; Peixoto AS; Magdalon J; Vieira TS; Andrade ML; Moreno MF; Chimin P; Câmara NO; Festuccia WT
Mol Nutr Food Res; 2018 Sep; 62(17):e1800283. PubMed ID: 30001482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
